Sarthak Metals Ltd ( ($IN:SMLT) ) has issued an update. Sarthak Metals Ltd has announced amendments to its Memorandum of Association, following ...

CSL Ltd (ASX: CSL) shares have gotten walloped since August. Is the ASX 200 biotech giant now a bargain buy or one to steer ...

A combination of a relatively low-risk approval process, growing sales, and a very attractive valuation based on management's peak sales estimations makes this biotech stock attractive.

Intellia Therapeutics finds itself navigating turbulent waters, with its stock price hitting fresh lows as a combination of clinical setbacks and insider sel ...